Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy.
neonatal hyperbilirubinemia
phototherapy
ursodeoxycholic acid
Journal
Clinical and experimental gastroenterology
ISSN: 1178-7023
Titre abrégé: Clin Exp Gastroenterol
Pays: New Zealand
ID NLM: 101532800
Informations de publication
Date de publication:
2019
2019
Historique:
received:
04
03
2019
accepted:
11
06
2019
entrez:
20
9
2019
pubmed:
20
9
2019
medline:
20
9
2019
Statut:
epublish
Résumé
Phototherapy is paramount in the management of high total serum bilirubin (TSB). Whether its effectiveness can be improved with ursodeoxycholic acid (UDCA) has not been evaluated among newborns of African descent. A double-blind-controlled study was used to evaluate the effect of UDCA on the management of high TSB in neonates. Recruited neonates were categorized into the experimental group (given UDCA plus phototherapy) and the control group (phototherapy and plain syrup), and their TSB and conjugated bilirubin levels were measured. The data were analyzed using SPSS version 20. Statistical significance was set at a The mean (SD) percentage reductions in TSB after 24 hrs were 40.73% (18.1) and 10.21% (7.1) in the experimental and control groups, respectively, and the difference was statistically significant ( Phototherapy is still effective in the management of neonatal hyperbilirubinemia, but inclusion of UDCA accentuates the reductive effect of phototherapy on the TSB in neonates, reducing the duration of treatment and in-patient care.
Sections du résumé
BACKGROUND
BACKGROUND
Phototherapy is paramount in the management of high total serum bilirubin (TSB). Whether its effectiveness can be improved with ursodeoxycholic acid (UDCA) has not been evaluated among newborns of African descent.
METHODS
METHODS
A double-blind-controlled study was used to evaluate the effect of UDCA on the management of high TSB in neonates. Recruited neonates were categorized into the experimental group (given UDCA plus phototherapy) and the control group (phototherapy and plain syrup), and their TSB and conjugated bilirubin levels were measured. The data were analyzed using SPSS version 20. Statistical significance was set at a
RESULTS
RESULTS
The mean (SD) percentage reductions in TSB after 24 hrs were 40.73% (18.1) and 10.21% (7.1) in the experimental and control groups, respectively, and the difference was statistically significant (
CONCLUSIONS
CONCLUSIONS
Phototherapy is still effective in the management of neonatal hyperbilirubinemia, but inclusion of UDCA accentuates the reductive effect of phototherapy on the TSB in neonates, reducing the duration of treatment and in-patient care.
Identifiants
pubmed: 31534356
doi: 10.2147/CEG.S207523
pii: 207523
pmc: PMC6681162
doi:
Types de publication
Journal Article
Langues
eng
Pagination
349-354Déclaration de conflit d'intérêts
The authors declare no conflicts of interest in this work.
Références
Pediatrics. 2001 Jul;108(1):25-30
pubmed: 11433050
J Invest Dermatol. 2001 Dec;117(6):1452-7
pubmed: 11886508
BJOG. 2003 Apr;110 Suppl 20:30-3
pubmed: 12763108
Clin Chem. 2004 Feb;50(2):279-87
pubmed: 14752012
Pediatrics. 2004 Jul;114(1):297-316
pubmed: 15231951
J Perinatol. 2005 Jan;25(1):54-9
pubmed: 15578034
Ital J Gastroenterol. 1992 Jan;24(1):31-5
pubmed: 1571577
J Perinatol. 2005 May;25(5):325-30
pubmed: 15716985
N Engl J Med. 2008 Feb 28;358(9):920-8
pubmed: 18305267
Arch Dis Child Fetal Neonatal Ed. 2009 Sep;94(5):F323-7
pubmed: 19000996
Pediatrics. 2009 Oct;124(4):1193-8
pubmed: 19786452
Trop Med Int Health. 2010 May;15(5):502-7
pubmed: 20412075
Acta Paediatr. 2011 Apr;100(4):499-505
pubmed: 21114525
Pediatr Res. 2011 Dec;70(6):560-5
pubmed: 21857383
Indian Pediatr. 2014 Mar;51(3):203-10
pubmed: 24736908
Front Neurosci. 2015 Mar 13;9:80
pubmed: 25821432
J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):97-100
pubmed: 26020375
Pediatrics. 1985 Feb;75(2 Pt 2):393-400
pubmed: 3881731
Pediatrics. 1985 Oct;76(4):579-84
pubmed: 4047802
Hepatology. 1995 Jul;22(1):82-7
pubmed: 7601437